NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market on Wednesday that its first quarter 2019 revenues rose 6 percent year over year, thanks largely to a 13 percent increase in revenues in its diagnostics and genomics business.

For the three months ended Jan. 31, the firm said revenues rose to $1.28 billion from $1.21 billion in Q1 2018, beating the Wall Street analysts' average estimate of $1.27 billion. The company said core revenues also grew 6 percent in Q1.